Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 4 , Pages 273-281 , December 2005

Systemic photodynamic therapy with Photofrin for naevoid basal cell carcinoma syndrome—A pilot study

  • V. Madan

      Affiliations

    • Dermatology Centre, Hope Hospital, Salford, Manchester, UK
    • ,
  • J. Loncaster

      Affiliations

    • Department of Clinical Oncology, Christie Hospital (NHS) Trust, Manchester, UK
    • ,
  • D. Allan

      Affiliations

    • North Western Medical Physics, Christie Hospital (NHS) Trust, Manchester, UK
    • ,
  • J. Lear

      Affiliations

    • Dermatology Centre, Hope Hospital, Salford, Manchester, UK
    • ,
  • L. Sheridan

      Affiliations

    • Department of Clinical Oncology, Christie Hospital (NHS) Trust, Manchester, UK
    • ,
  • C. Leach

      Affiliations

    • Department of Clinical Oncology, Christie Hospital (NHS) Trust, Manchester, UK
    • ,
  • E. Allan, FRCR

      Affiliations

    • Department of Clinical Oncology, Christie Hospital (NHS) Trust, Manchester, UK
    • Corresponding Author InformationCorresponding author.

References 

  1. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med. 2004;6(November–December (6)):530–539
  2. Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet. 2001;10(April (7)):757–762
  3. Quinn AG, Epstein E. Patched, hedgehog, and skin cancer. Methods Mol Biol. 2003;222:85–95
  4. Evans DG, Farndon PA, Burnell LD, Gattameni HR, Birch JM. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer. 1991;64:959–961
  5. Kopera D, Cerroni L, Fink-Puches R, et al. Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol. 1996 May;34(May (5 Pt 2)):937–939
  6. Dougherty TJ, Gomer CJ, Henderson BW. Photodynamic therapy. J Natl Cancer Inst. 1998;90(June (12)):889–905
  7. Itkin A, Gilchrest BA. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg. 2004;30(July (7)):1054–1061
  8. Dijkstra AT, Majoie IM, van Dongen JW. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis. Bowen's disease and basal cell carcinoma. J Eur Acad Dermatol Venereol. 2001;15(November (6)):550–554
  9. Oseroff AR, Shieh S, Frawley NP. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol. 2005;141(January (1)):60–67
  10. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?. J Am Acad Dermatol. 1993;28(January (1)):17–21Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?. J Am Acad Dermatol. 1993;29(July (1)):41
  11. Allan E, Pye DA, Levine EL, Moore JV. Non-invasive pulsed ultrasound quantification of the resolution of basal cell carcinomas after photodynamic therapy. Lasers Med Sci. 2002;17(4):230–237
  12. Moran CM, Bush NL, Bamber JC. Ultrasonic propagation properties of excised human skin. Ultrasound Med Biol. 1995;21(9):1177–1190
  13. Lui H, Anderson RR. Photodynamic therapy in dermatology: recent developments. Dermatol Clin. 1993;11(January (1)):1–13
  14. Bissonnette R, Lui H. Current status of photodynamic therapy in dermatology. Dermatol Clin. 1997;15(July (3)):507–519
  15. AxcanPharmaInc Website: http://www.axcan.com/photofrin/productinfo.php?lang=1. Accessed on June 18, 2005.
  16. Calzavara-Pinton PG, Szeimies RM, Ortel B. Photodynamic therapy with systemic administration of photosensitizers in dermatology. J Photochem Photobiol B. 1996;36(November (2)):225–231
  17. Wilson BD, Mang TS, Stoll H, Jones C, Cooper M, Dougherty TJ. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol. 1992;28(December (12)):1597–1601
  18. Keller GS, Razum NJ, Doiron DR. Photodynamic therapy for non melanoma skin cancer. Facial Plast Surg. 1989;6(Spring (3)):180–184
  19. Reynolds T. Photodynamic therapy expands its horizons. Natl Cancer Inst. 1997;89(January (2)):112–124
  20. Roberts DJ, Cairnduff F. Photodynamic therapy of primary skin cancer: a review. Br J Plast Surg. 1995;48(September (6)):360–370
  21. Tse DT, Kersten RC, Anderson RL. Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report. Arch Ophthalmol. 1984;102(July (7)):990–994
  22. Rifkin R, Reed B, Hetzel F, Chen K. Photodynamic therapy using SnET2 for basal cell nevus syndrome: a case report. Clin Ther. 1997;19(July–August (4)):639–641
  23. Ochsner M. Photodynamic therapy: the clinical perspective. Review on applications for control of diverse tumorous and non-tumorous diseases. Arzneimittelforschung. 1997;47(November (11)):1185–1194
  24. Gomer CJ. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol. 1991;54(December (6)):1093–1107
  25. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?. J Am Acad Dermatol. 1993;28(January (1)):17–21
  26. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 1995;133(August (2)):282–288
  27. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79(June (12)):2282–2308
  28. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B. 1995;29(July (1)):53–57
  29. Martin A, Tope WD, Grevelink JM, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res. 1995;287(7):665–674
  30. Peng Q, Warloe T, Moan J, et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol. 1995;62(November (5)):906–913
  31. Morton CA. Photodynamic therapy for nonmelanoma skin cancer—and more?. Arch Dermatol. 2004;140(January (1)):116–120
  32. Morton CA, MacKie RM, Whitehurst C, Moore JV, McColl JH. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol. 1998;134(February (2)):248–249
  33. Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144(March (3)):567–574
  34. Fornage BD, McGavran MH, Duvic M, Waldron CA. Imaging of the skin with 20-MHz US. Radiology. 1993;189(October (1)):69–76

PII: S1572-1000(05)00101-8

doi: 10.1016/S1572-1000(05)00101-8

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 4 , Pages 273-281 , December 2005

Article Tools

* Image Usage & Resolution